Abstract
Dimerized translationally controlled tumor protein (dTCTP) plays a role in allergic diseases. A 7-mer peptide, dimerized translationally binding protein 2 (dTBP2), binds to dTCTP and inhibits dTCTP, suggesting that the 7-mer peptide may have therapeutic potential. We assessed the safety of dTBP2 by examining its cytotoxicity to both human bronchial epithelial cells and mice. dTBP2 did not cause cytotoxicity to the epithelial cells in concentrations up to 100 μg/ml. Also, dTBP2 caused no adverse effects upon repeated administration of 50 mg/kg over 24 h to mice. Hence, we conclude that dTBP2 is a safe candidate drug for use in the therapy of allergic diseases.
Original language | English |
---|---|
Pages (from-to) | 1119-1125 |
Number of pages | 7 |
Journal | Human and Experimental Toxicology |
Volume | 32 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2013 |
Keywords
- allergy
- cytotoxicity
- Dimerized TCTP
- dTBP2
- repeated-dose toxicity
- safety